Skip to main content

Science Translational Medicine: Parkinson’s Disease Biomarkers Are Needed to Accelerate Therapeutic Development

By Todd Sherer

ABSTRACT:

Biomarkers for detecting the early stages of Parkinson’s disease (PD) could accelerate development of new treatments. Such biomarkers could be used to identify individuals at risk for developing PD, to improve early diagnosis, to track disease progression with precision, and to test the efficacy of new treatments. Although some progress has been made, there are many challenges associated with developing biomarkers for detecting PD in its earliest stages.

FULL TEXT:

To read the full text of this article, click here.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.